In vivo activation of a mutant -opioid receptor by antagonist: Future direction for opiate pain treatment paradigm that lacks undesirable side effects-Reference-Cited by-同舟云学术

In vivo activation of a mutant -opioid receptor by antagonist: Future direction for opiate pain treatment paradigm that lacks undesirable side effects

Published:2003-01-13 Issue:4 Volume:100 Page:2117-2121
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Law P.-Y.,Yang J. W.,Guo X.,Loh H. H.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference33 articles.

1. The neurobiology of pain

2. Nociceptive integration: Does it have a peripheral component?

3. The pharmacological basis of contemporary pain management

4. Kinins and their receptors in hyperalgesia

5. Spinal cord pharmacology of pain

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transformer-based classification of visceral pain-related local field potential patterns in the brain;2024-07-29

2. Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia;Cell Chemical Biology;2024-07

3. Pillar[6]MaxQ: A potent supramolecular host for in vivo sequestration of methamphetamine and fentanyl;Chem;2023-04

4. Selective and antagonist-dependent µ-opioid receptor activation by the combination of 2-{[2-(6-chloro-3,4-dihydro-1(2H)-quinolinyl)-2-oxoethyl]sulfanyl}-5-phenyl-4,6-(1H,5H)-pyrimidinedione and naloxone/naltrexone;Bioorganic Chemistry;2022-11

5. The in vivo antinociceptive and μ-opioid receptor activating effects of the combination of N-phenyl-2′,4′-dimethyl-4,5′-bi-1,3-thiazol-2-amines and naloxone;European Journal of Medicinal Chemistry;2019-04